In what could become a new twist in the ongoing patent dispute over the Apple Watch’s Blood Oxygen sensor, the CEO of Masimo, ...

Just a week after being unseated from his position as the board’s chairman, Masimo’s founder has resigned from his position ...

Masimo CEO Joe Kiani may have waged and won a patent dispute against Apple over its blood oxygen sensor, he has stepped down ...

Wells Fargo analyst Vik Chopra maintained a Buy rating on Masimo (MASI – Research Report) yesterday and set a price target of $160.00.

Former Masimo CEO Joe Kiani may have won the war against Apple, but he has resigned after losing a fight with a hedge fund.

Masimo CEO Joe Kiani stepped down following a two-year skirmish with an activist investor that ejected him from his own board ...

Medical tech company Masimo ( MASI) had some significant C-suite news to report on Wednesday, and investors clearly welcomed ...

Joe Kiani’s reign at Masimo Corp. abruptly ended following a vote at the annual shareholders meeting on Sept. 19 that saw ...

Apple and Masimo have been battling it out in court after the company specializing in health technologies managed to ...

Masimo stock jumped Wednesday after Chief Executive Joe Kiani resigned. But, importantly, the company's other executives ...

Today the Board of Directors (the “Board”) of Masimo (Nasdaq: MASI) a leading global medical innovator, provided a series of leadership and business u ...

Michelle Brennan was named acting CEO of the patient monitoring company following Joe Kiani’s defeat in a proxy battle with an activist investor.